Alteration in liver function following use of remdesivir in COVID-19 patients: A prospective study
Hepatology International
; 16:S302, 2022.
Article
in English
| EMBASE | ID: covidwho-1995904
ABSTRACT
Objectives:
Background:
COVID-19 infection has been affecting humans globally since December, 2019 and Remdesivir was first approved by FDA for treating severe COVID-19 pneumonia in July, 2020 though its hepatic safety has not been adequately studied. Remdesivir, a nucleotide analog prodrug, has been found to create derangement in liver function. However, COVID-19 infection itself has transient implications over liver enzymes.Aims:
To evaluate the effect of Remdesivir on liver function in COVID-19 in-patients with normal liver function. Materials andMethods:
This prospective study was conducted at Mediplus Hospital and Trauma Center from 1st September, 2020 to 31st May, 2021. Ethical approval was obtained and 107 PCR positive COVID-19 in-patients with normal liver function test (LFT) were included in the study. Liver enzymes ( alanine and aspartate transaminases and alkaline phosphatases) and serum bilirubin were sent after 72 h of initiation of the drug. Data was entered in Microsoft excel and result studied.Results:
Out of 125 included patients, LFT became deranged in 39 (31.2%) patients. Among those 39 patients, 16 (41.0%) had isolated raised ALT, 9 (23.1%) had isolated raised AST and 14 (35.9%) had all three enzymes (AST, ALT and ALP) raised, while serum bilirubin was found to be raised in only 11 (28.2%) (Diagram1).Conclusion:
Biochemical alteration in liver function has been noted in Covid-19 patients after the Remdesivir therapy. However, that effect could also be due to hepatic implications of Covid-19 infection itself and concomitant use of other drugs.
alanine; alkaline phosphatase; aspartate aminotransferase; bilirubin; endogenous compound; liver enzyme; remdesivir; adult; alanine aminotransferase blood level; aspartate aminotransferase level; bilirubin blood level; conference abstract; controlled study; coronavirus disease 2019; drug therapy; emergency health service; female; hospital patient; human; human tissue; liver function; liver function test; major clinical study; male; prospective study; software
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Cohort study
/
Observational study
/
Prognostic study
Language:
English
Journal:
Hepatology International
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS